$KERX Recent News Nasdaq extends break to less-c
Post# of 102250
Posted On: 12/06/2013 12:52:51 PM
$KERX Recent News
Nasdaq extends break to less-charted territory 11:42 a.m. Dec. 2, 2013 - Michael Ashbaugh
6 movers to watch 2:08 p.m. Nov. 6, 2013 - The Trading Deck
Keryx climbs after treatment shows positive result 10:01 a.m. Nov. 5, 2013 - MarketWatch.com
Six stocks to watch for some upside 2:21 p.m. April 11, 2013 - The Trading Deck
6 gut checks before the stock market's opening bell 6:47 a.m. March 7, 2013 - Shawn Langlois
Towerstream, Vanguard and others price offerings 10:32 a.m. Jan. 31, 2013 - MarketWatch.com
6 gut checks before the stock market's opening bell 6:52 a.m. Jan. 31, 2013 - Shawn Langlois
Keryx Biopharmaceuticals up 8.5% in premarket 7:58 a.m. Jan. 29, 2013 - Steve Gelsi
Monday’s movers: Herbalife clobbered on FTC news 4:30 p.m. Jan. 28, 2013 - Sue Chang
In focus: No letup by the bulls 7:45 p.m. Jan. 23, 2013 - Lawrence G. McMillan
Keryx Biopharma rises 17% in premarket trades 7:36 a.m. Jan. 23, 2013 - Steve Gelsi
Monday’s biggest gaining and declining stocks 3:37 p.m. April 23, 2012 - MarketWatch
Monday’s biggest gaining & declining stocks 4:56 p.m. April 2, 2012 - Kate Gibson
Keryx, AEterna implode on failed drug study 10:13 a.m. April 2, 2012 - Val Brickates Kennedy
Keryx, AEterna rally ahead of study results 12:34 p.m. March 16, 2012 - Val Brickates Kennedy
Keryx , AEterna rally ahead of study results 12:32 p.m. March 16, 2012 - Val Brickates Kennedy
Top longs and shorts to watch 12:18 p.m. March 6, 2012 - The Trading Deck
AEterna, Keryx soar on study speculation 12:52 p.m. March 5, 2012 - Val Brickates Kennedy
Keryx Biopharmaceuticals Inc. shares gain 9.6% 9:35 a.m. Nov. 30, 2010 - Kate Gibson
Powerful uptrend meets major resistance 9:28 a.m. Oct. 25, 2010 - Michael Ashbaugh
Biotech Stock Mailbag: Enteromedics, ARCA Biopharma, Keryx Pharma 6:00 a.m. Today - TheStreet.com
Zerenex- The New Spark For Keryx? 7:42 a.m. Nov. 25, 2013 - Seeking Alpha
Commit To Buy Keryx Biopharmaceuticals At $8, Earn 28.1% Using Options 1:29 p.m. Nov. 19, 2013 - TheStreet.com
Why Doctors, Dialysis Providers And Investors Are Excited About Zerenex 10:12 a.m. Nov. 11, 2013 - Seeking Alpha
Key Issues Surrounding The Zalicus Catalyst Trade 8:56 a.m. Nov. 8, 2013 - Seeking Alpha
Keryx Biopharma Issues Update from Ongoing Zerenex LT Safety Extension Study 7:33 a.m. Nov. 8, 2013 - benzinga.com
Keryx Should Continue To Climb 5:04 a.m. Nov. 8, 2013 - Seeking Alpha
Biotech Stock Mailbag: Galectin, Keryx, Navidea, Cytori 6:10 p.m. Nov. 7, 2013 - TheStreet.com
Perilous Reversal Stock: Keryx Biopharmaceuticals (KERX) 10:29 a.m. Nov. 7, 2013 - TheStreet.com
UPDATE: J.P. Morgan Reiterates on Keryx Biopharmaceuticals on Model Update After Positive NDD-CKD Data 9:12 a.m. Nov. 7, 2013 - benzinga.com
Keryx Biopharmaceuticals' CEO Discusses Q3 2013 Results - Earnings Call Transcript 1:48 a.m. Nov. 6, 2013 - Seeking Alpha
Data Support Keryx's Anemia Drug In A New And Large Market 1:43 p.m. Nov. 5, 2013 - Seeking Alpha
Four Big Healthy Biotech Gainers, One Big Loser 1:07 p.m. Nov. 5, 2013 - 247WallSt.com
Keryx Biopharmaceuticals Announces Zerenex(TM) (ferric citrate coordination complex) Meets All Primary and Key Secondary Endpoints in Phase 2 Study 6:36 a.m. Nov. 5, 2013 - benzinga.com
10-Q: KERYX BIOPHARMACEUTICALS INC 5:05 p.m. Nov. 4, 2013 - Edgar Online - (EDG = 10Q, 10K)
UPDATE: JMP Securities Reiterates on Keryx Biopharmaceuticals on Blockbuster Potential Growing for Zerenex 8:17 a.m. Nov. 4, 2013 - benzinga.com
A Look Back At Biotech Short Picks 2:18 p.m. Oct. 31, 2013 - Seeking Alpha
4 Biotech Stocks Making Headlines 10:25 a.m. Oct. 28, 2013 - Wall St. Cheat Sheet
Sunshine Heart's Pulse System Could Revolutionize How Heart Failure Is Treated 8:59 a.m. Oct. 21, 2013 - Seeking Alpha
Trade-Ideas: Keryx Biopharmaceuticals (KERX) Is Today's "Perilous Reversal" Stock 10:44 a.m. Oct. 18, 2013 - TheStreet.com
Stock Initiation of the Day: Keryx Biopharma, GlaxoSmithKline, AstraZeneca, and Raptor Pharma 10:48 a.m. Today - PR Newswire
Regulatory Approval, Requisite Consents and Expiration of Consent Solicitations, and Stock Price Movements - Research Report on Thermo Fisher, Endo, Perrigo, Keryx, and Waters 8:00 a.m. Dec. 4, 2013 - PR Newswire
Bullish Trend Analysis: Tesla Motors Inc, XOMA Corp, Keryx Biopharmaceuticals, Oncomed Pharmaceuticals 9:01 a.m. Dec. 3, 2013 - ACCESSWIRE
Grants and Stock Movements of Major Drug Manufacturers - Research Report on AbbVie, Keryx Biopharmaceuticals, Pacira Pharmaceuticals, Rockwell Medical, and Impax Laboratories 8:00 a.m. Nov. 22, 2013 - PR Newswire
Extension Study Data, Financial Results, Scheduled Conferences and Presentations - Research Report on Keryx, Raptor, Pacira, Horizon Pharma, and Impax 8:00 a.m. Nov. 13, 2013 - PR Newswire
Morning Research: GlaxoSmithKline PLC, Keryx Biopharma Inc., AstraZeneca PLC, and Raptor Pharma Corp. 8:00 a.m. Nov. 11, 2013 - PR Newswire
IPO, Earnings & Corporate Developments: Twitter, Vale SA, OCZ Technology Group, Radian Group, Keryx Biopharmaceuticals 8:46 a.m. Nov. 8, 2013 - PR Newswire
Keryx Biopharmaceuticals Provides Update From Ongoing Zerenex(TM) (ferric citrate coordination complex) Long-Term Safety Extension Study in Patients With Hyperphosphatemia on Dialysis 8:30 a.m. Nov. 8, 2013 - GlobeNewswire
Legal Settlements, Stock Price Updates, Financial Results, and Commencement of Clinical Studies - Research Report on Johnson & Johnson, Elan, Tenet, Opko and Keryx Biopharmaceuticals 8:00 a.m. Nov. 7, 2013 - PR Newswire
M&A, Earnings and News Round Up: Keryx Biopharmaceuticals, Pandora Media, Marvell Technology Group, Starbucks, Cell Therapeutics 8:46 a.m. Nov. 6, 2013 - PR Newswire
Keryx Biopharmaceuticals to Hold Conference Call Tomorrow, November 5, 2013, at 8:30AM ET to Discuss Top-Line Results from Zerenex(TM) Phase 2 Study of Non-Dialysis Dependent Chronic Kidney Disease Patients with Elevated Serum Phosphorus and Iron Deficiency Anemia 5:00 p.m. Nov. 4, 2013 - GlobeNewswire
Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2013 Financial Results 4:30 p.m. Nov. 4, 2013 - GlobeNewswire
Quarterly Reports, License Applications, and Abstract Presentations - Research on Elan, NPS, ICON, Keryx, and Healthways 9:00 a.m. Oct. 29, 2013 - PR Newswire
Keryx Biopharmaceuticals Announces PDUFA Goal Date for Zerenex(TM) New Drug Application 8:30 a.m. Oct. 21, 2013 - GlobeNewswire
Financial Results, Quarterly Earnings Schedules, Marketing Authorizations, Completed Acquisitions, and New Drug Applications - Research Report on Johnson & Johnson, AbbVie, GSK, AstraZeneca, and Keryx 8:00 a.m. Oct. 18, 2013 - PR Newswire
Technical Study: AstraZeneca PLC, GlaxoSmithKline PLC, Keryx Biopharma Inc., and Raptor Pharma Corp. 12:51 p.m. Oct. 17, 2013 - PR Newswire
Critical Alerts For Goldman Sachs, Netflix, Nasdaq, Aetna, and Keryx Biopharmaceuticals Released By InvestorsObserver 9:31 a.m. Oct. 17, 2013 - PR Newswire
Keryx Biopharmaceuticals' Zerenex(TM) (Ferric Citrate Coordination Complex) Data Selected for Oral and Poster Presentations at the American Society of Nephrology's Kidney Week 2013 8:31 a.m. Oct. 17, 2013 - GlobeNewswire
Drug Approvals, Data Presentations, Clinical Trials, New Appointments, and Corporate Events - Research Report on Johnson & Johnson, Novo Nordisk, Isis, Keryx, and The Medicines Company 8:00 a.m. Oct. 9, 2013 - PR Newswire
Keryx Biopharmaceuticals Announces FDA Acceptance for Filing of Zerenex(TM) New Drug Application 8:30 a.m. Oct. 8, 2013 - GlobeNewswire
Nasdaq extends break to less-charted territory 11:42 a.m. Dec. 2, 2013 - Michael Ashbaugh
6 movers to watch 2:08 p.m. Nov. 6, 2013 - The Trading Deck
Keryx climbs after treatment shows positive result 10:01 a.m. Nov. 5, 2013 - MarketWatch.com
Six stocks to watch for some upside 2:21 p.m. April 11, 2013 - The Trading Deck
6 gut checks before the stock market's opening bell 6:47 a.m. March 7, 2013 - Shawn Langlois
Towerstream, Vanguard and others price offerings 10:32 a.m. Jan. 31, 2013 - MarketWatch.com
6 gut checks before the stock market's opening bell 6:52 a.m. Jan. 31, 2013 - Shawn Langlois
Keryx Biopharmaceuticals up 8.5% in premarket 7:58 a.m. Jan. 29, 2013 - Steve Gelsi
Monday’s movers: Herbalife clobbered on FTC news 4:30 p.m. Jan. 28, 2013 - Sue Chang
In focus: No letup by the bulls 7:45 p.m. Jan. 23, 2013 - Lawrence G. McMillan
Keryx Biopharma rises 17% in premarket trades 7:36 a.m. Jan. 23, 2013 - Steve Gelsi
Monday’s biggest gaining and declining stocks 3:37 p.m. April 23, 2012 - MarketWatch
Monday’s biggest gaining & declining stocks 4:56 p.m. April 2, 2012 - Kate Gibson
Keryx, AEterna implode on failed drug study 10:13 a.m. April 2, 2012 - Val Brickates Kennedy
Keryx, AEterna rally ahead of study results 12:34 p.m. March 16, 2012 - Val Brickates Kennedy
Keryx , AEterna rally ahead of study results 12:32 p.m. March 16, 2012 - Val Brickates Kennedy
Top longs and shorts to watch 12:18 p.m. March 6, 2012 - The Trading Deck
AEterna, Keryx soar on study speculation 12:52 p.m. March 5, 2012 - Val Brickates Kennedy
Keryx Biopharmaceuticals Inc. shares gain 9.6% 9:35 a.m. Nov. 30, 2010 - Kate Gibson
Powerful uptrend meets major resistance 9:28 a.m. Oct. 25, 2010 - Michael Ashbaugh
Biotech Stock Mailbag: Enteromedics, ARCA Biopharma, Keryx Pharma 6:00 a.m. Today - TheStreet.com
Zerenex- The New Spark For Keryx? 7:42 a.m. Nov. 25, 2013 - Seeking Alpha
Commit To Buy Keryx Biopharmaceuticals At $8, Earn 28.1% Using Options 1:29 p.m. Nov. 19, 2013 - TheStreet.com
Why Doctors, Dialysis Providers And Investors Are Excited About Zerenex 10:12 a.m. Nov. 11, 2013 - Seeking Alpha
Key Issues Surrounding The Zalicus Catalyst Trade 8:56 a.m. Nov. 8, 2013 - Seeking Alpha
Keryx Biopharma Issues Update from Ongoing Zerenex LT Safety Extension Study 7:33 a.m. Nov. 8, 2013 - benzinga.com
Keryx Should Continue To Climb 5:04 a.m. Nov. 8, 2013 - Seeking Alpha
Biotech Stock Mailbag: Galectin, Keryx, Navidea, Cytori 6:10 p.m. Nov. 7, 2013 - TheStreet.com
Perilous Reversal Stock: Keryx Biopharmaceuticals (KERX) 10:29 a.m. Nov. 7, 2013 - TheStreet.com
UPDATE: J.P. Morgan Reiterates on Keryx Biopharmaceuticals on Model Update After Positive NDD-CKD Data 9:12 a.m. Nov. 7, 2013 - benzinga.com
Keryx Biopharmaceuticals' CEO Discusses Q3 2013 Results - Earnings Call Transcript 1:48 a.m. Nov. 6, 2013 - Seeking Alpha
Data Support Keryx's Anemia Drug In A New And Large Market 1:43 p.m. Nov. 5, 2013 - Seeking Alpha
Four Big Healthy Biotech Gainers, One Big Loser 1:07 p.m. Nov. 5, 2013 - 247WallSt.com
Keryx Biopharmaceuticals Announces Zerenex(TM) (ferric citrate coordination complex) Meets All Primary and Key Secondary Endpoints in Phase 2 Study 6:36 a.m. Nov. 5, 2013 - benzinga.com
10-Q: KERYX BIOPHARMACEUTICALS INC 5:05 p.m. Nov. 4, 2013 - Edgar Online - (EDG = 10Q, 10K)
UPDATE: JMP Securities Reiterates on Keryx Biopharmaceuticals on Blockbuster Potential Growing for Zerenex 8:17 a.m. Nov. 4, 2013 - benzinga.com
A Look Back At Biotech Short Picks 2:18 p.m. Oct. 31, 2013 - Seeking Alpha
4 Biotech Stocks Making Headlines 10:25 a.m. Oct. 28, 2013 - Wall St. Cheat Sheet
Sunshine Heart's Pulse System Could Revolutionize How Heart Failure Is Treated 8:59 a.m. Oct. 21, 2013 - Seeking Alpha
Trade-Ideas: Keryx Biopharmaceuticals (KERX) Is Today's "Perilous Reversal" Stock 10:44 a.m. Oct. 18, 2013 - TheStreet.com
Stock Initiation of the Day: Keryx Biopharma, GlaxoSmithKline, AstraZeneca, and Raptor Pharma 10:48 a.m. Today - PR Newswire
Regulatory Approval, Requisite Consents and Expiration of Consent Solicitations, and Stock Price Movements - Research Report on Thermo Fisher, Endo, Perrigo, Keryx, and Waters 8:00 a.m. Dec. 4, 2013 - PR Newswire
Bullish Trend Analysis: Tesla Motors Inc, XOMA Corp, Keryx Biopharmaceuticals, Oncomed Pharmaceuticals 9:01 a.m. Dec. 3, 2013 - ACCESSWIRE
Grants and Stock Movements of Major Drug Manufacturers - Research Report on AbbVie, Keryx Biopharmaceuticals, Pacira Pharmaceuticals, Rockwell Medical, and Impax Laboratories 8:00 a.m. Nov. 22, 2013 - PR Newswire
Extension Study Data, Financial Results, Scheduled Conferences and Presentations - Research Report on Keryx, Raptor, Pacira, Horizon Pharma, and Impax 8:00 a.m. Nov. 13, 2013 - PR Newswire
Morning Research: GlaxoSmithKline PLC, Keryx Biopharma Inc., AstraZeneca PLC, and Raptor Pharma Corp. 8:00 a.m. Nov. 11, 2013 - PR Newswire
IPO, Earnings & Corporate Developments: Twitter, Vale SA, OCZ Technology Group, Radian Group, Keryx Biopharmaceuticals 8:46 a.m. Nov. 8, 2013 - PR Newswire
Keryx Biopharmaceuticals Provides Update From Ongoing Zerenex(TM) (ferric citrate coordination complex) Long-Term Safety Extension Study in Patients With Hyperphosphatemia on Dialysis 8:30 a.m. Nov. 8, 2013 - GlobeNewswire
Legal Settlements, Stock Price Updates, Financial Results, and Commencement of Clinical Studies - Research Report on Johnson & Johnson, Elan, Tenet, Opko and Keryx Biopharmaceuticals 8:00 a.m. Nov. 7, 2013 - PR Newswire
M&A, Earnings and News Round Up: Keryx Biopharmaceuticals, Pandora Media, Marvell Technology Group, Starbucks, Cell Therapeutics 8:46 a.m. Nov. 6, 2013 - PR Newswire
Keryx Biopharmaceuticals to Hold Conference Call Tomorrow, November 5, 2013, at 8:30AM ET to Discuss Top-Line Results from Zerenex(TM) Phase 2 Study of Non-Dialysis Dependent Chronic Kidney Disease Patients with Elevated Serum Phosphorus and Iron Deficiency Anemia 5:00 p.m. Nov. 4, 2013 - GlobeNewswire
Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2013 Financial Results 4:30 p.m. Nov. 4, 2013 - GlobeNewswire
Quarterly Reports, License Applications, and Abstract Presentations - Research on Elan, NPS, ICON, Keryx, and Healthways 9:00 a.m. Oct. 29, 2013 - PR Newswire
Keryx Biopharmaceuticals Announces PDUFA Goal Date for Zerenex(TM) New Drug Application 8:30 a.m. Oct. 21, 2013 - GlobeNewswire
Financial Results, Quarterly Earnings Schedules, Marketing Authorizations, Completed Acquisitions, and New Drug Applications - Research Report on Johnson & Johnson, AbbVie, GSK, AstraZeneca, and Keryx 8:00 a.m. Oct. 18, 2013 - PR Newswire
Technical Study: AstraZeneca PLC, GlaxoSmithKline PLC, Keryx Biopharma Inc., and Raptor Pharma Corp. 12:51 p.m. Oct. 17, 2013 - PR Newswire
Critical Alerts For Goldman Sachs, Netflix, Nasdaq, Aetna, and Keryx Biopharmaceuticals Released By InvestorsObserver 9:31 a.m. Oct. 17, 2013 - PR Newswire
Keryx Biopharmaceuticals' Zerenex(TM) (Ferric Citrate Coordination Complex) Data Selected for Oral and Poster Presentations at the American Society of Nephrology's Kidney Week 2013 8:31 a.m. Oct. 17, 2013 - GlobeNewswire
Drug Approvals, Data Presentations, Clinical Trials, New Appointments, and Corporate Events - Research Report on Johnson & Johnson, Novo Nordisk, Isis, Keryx, and The Medicines Company 8:00 a.m. Oct. 9, 2013 - PR Newswire
Keryx Biopharmaceuticals Announces FDA Acceptance for Filing of Zerenex(TM) New Drug Application 8:30 a.m. Oct. 8, 2013 - GlobeNewswire
(0)
(0)Scroll down for more posts ▼